These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 17582780

  • 1. Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.
    Bellosta S, Baetta R, Canavesi M, Comparato C, Granata A, Monetti M, Cairoli F, Eberini I, Puglisi L, Corsini A.
    Pharmacol Res; 2007 Aug; 56(2):160-7. PubMed ID: 17582780
    [Abstract] [Full Text] [Related]

  • 2. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
    Luan Z, Chase AJ, Newby AC.
    Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):769-75. PubMed ID: 12663370
    [Abstract] [Full Text] [Related]

  • 3. NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells.
    Rodríguez-Calvo R, Ferrán B, Alonso J, Martí-Pàmies I, Aguiló S, Calvayrac O, Rodríguez C, Martínez-González J.
    Thromb Haemost; 2015 Jun 01; 113(6):1323-34. PubMed ID: 25809189
    [Abstract] [Full Text] [Related]

  • 4. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
    Hlawaty H, Jacob MP, Louedec L, Letourneur D, Brink C, Michel JB, Feldman L, Bäck M.
    Arterioscler Thromb Vasc Biol; 2009 Apr 01; 29(4):518-24. PubMed ID: 19164806
    [Abstract] [Full Text] [Related]

  • 5. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
    Lee CS, Kwon YW, Yang HM, Kim SH, Kim TY, Hur J, Park KW, Cho HJ, Kang HJ, Park YB, Kim HS.
    Arterioscler Thromb Vasc Biol; 2009 Apr 01; 29(4):472-9. PubMed ID: 19201691
    [Abstract] [Full Text] [Related]

  • 6. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
    Borst O, Schaub M, Walker B, Schmid E, Münzer P, Voelkl J, Alesutan I, Rodríguez JM, Vogel S, Schoenberger T, Metzger K, Rath D, Umbach A, Kuhl D, Müller II, Seizer P, Geisler T, Gawaz M, Lang F.
    Arterioscler Thromb Vasc Biol; 2015 Mar 01; 35(3):547-57. PubMed ID: 25614279
    [Abstract] [Full Text] [Related]

  • 7. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
    Augé N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S, Krell HW, Salvayre R, Nègre-Salvayre A.
    Circulation; 2004 Aug 03; 110(5):571-8. PubMed ID: 15277330
    [Abstract] [Full Text] [Related]

  • 8. Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells.
    Wołczynski S, Surazyński A, Swiatecka J, Pałka J.
    Gynecol Endocrinol; 2001 Jun 03; 15(3):225-33. PubMed ID: 11447735
    [Abstract] [Full Text] [Related]

  • 9. Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration.
    Kim J, Ko J.
    FASEB J; 2014 Nov 03; 28(11):5010-21. PubMed ID: 25077563
    [Abstract] [Full Text] [Related]

  • 10. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
    Oak MH, El Bedoui J, Anglard P, Schini-Kerth VB.
    Circulation; 2004 Sep 28; 110(13):1861-7. PubMed ID: 15364805
    [Abstract] [Full Text] [Related]

  • 11. Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels.
    Bonta PI, Matlung HL, Vos M, Peters SL, Pannekoek H, Bakker EN, de Vries CJ.
    Cardiovasc Res; 2010 Aug 01; 87(3):561-8. PubMed ID: 20189954
    [Abstract] [Full Text] [Related]

  • 12. Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells.
    Lee EJ, Kim DI, Kim WJ, Moon SK.
    Mol Nutr Food Res; 2009 Dec 01; 53(12):1582-91. PubMed ID: 19810018
    [Abstract] [Full Text] [Related]

  • 13. Raloxifene upregulated mesangial cell MMP-2 activity via ER-β through transcriptional regulation.
    Fang M, Wu XC, Huang W.
    Cell Biochem Biophys; 2013 Nov 01; 67(2):607-13. PubMed ID: 23471663
    [Abstract] [Full Text] [Related]

  • 14. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
    Butoi ED, Gan AM, Manduteanu I, Stan D, Calin M, Pirvulescu M, Koenen RR, Weber C, Simionescu M.
    Biochim Biophys Acta; 2011 Dec 01; 1813(12):2026-35. PubMed ID: 21888931
    [Abstract] [Full Text] [Related]

  • 15. Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure.
    Grandas OH, Mountain DH, Kirkpatrick SS, Cassada DC, Stevens SL, Freeman MB, Goldman MH.
    J Vasc Surg; 2009 Jan 01; 49(1):185-91. PubMed ID: 18829229
    [Abstract] [Full Text] [Related]

  • 16. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
    Lepetit H, Eddahibi S, Fadel E, Frisdal E, Munaut C, Noel A, Humbert M, Adnot S, D'Ortho MP, Lafuma C.
    Eur Respir J; 2005 May 01; 25(5):834-42. PubMed ID: 15863640
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury.
    Bendeck MP, Irvin C, Reidy MA.
    Circ Res; 1996 Jan 01; 78(1):38-43. PubMed ID: 8603503
    [Abstract] [Full Text] [Related]

  • 18. Selective estrogen receptor modulators prevent neointima formation after vascular injury.
    Savolainen-Peltonen H, Luoto NM, Kangas L, Häyry P.
    Mol Cell Endocrinol; 2004 Nov 30; 227(1-2):9-20. PubMed ID: 15501580
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase expression and activity in human airway smooth muscle cells.
    Elshaw SR, Henderson N, Knox AJ, Watson SA, Buttle DJ, Johnson SR.
    Br J Pharmacol; 2004 Aug 30; 142(8):1318-24. PubMed ID: 15265805
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
    Kim HM, Bae SJ, Kim DW, Kim BK, Lee SB, Lee US, Kim CH, Moon SK.
    Int Immunopharmacol; 2007 Aug 30; 7(8):1083-91. PubMed ID: 17570325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.